(b)(4).Bleeding was reported through the graft material.A review of qc, manufacturing and physical test records was performed and showed that batch was manufactured to design specification.All released grafts from batch also met acceptance criteria for all physical tests on base material and in process testing.A five-year review (jan 15 - feb 20) of similar events was performed for graft leakage (oozing) related events.A similar event rate of 0.015% (rate=complaints v sales) was confirmed for all gelweave variants.There have been no similar complaints received from other units from this batch and no negative trend has been identified.Actual device remains implanted, therefore no testing could be performed.Review of product batch records showed no issue with the manufacture of this batch.From the information received, users failure to rinse the device for 5 mins prior to the procedure may have contributed to the leakage seen.Vascutek ltd, now considers this complaint closed.Further action is not planned, however, the issue will be tracked and trended as part of the on-going complaints trending and reporting process and if an adverse trend develops action may be taken at that time.
|